$0.49 $0.00 (0.3%)

04:00 PM EST on 12/06/19

Organovo Hldgs Inc (NASDAQ:ONVO)

CAPS Rating: 2 out of 5

Current Price $0.49 Mkt Cap $64.0M
Open $0.49 P/E Ratio 0.00
Prev. Close $0.49 Div. (Yield) $0.00 (0.0%)
Daily Range $0.49 - $0.50 Volume 204,811
52-Wk Range $0.22 - $1.18 Avg. Daily Vol. 580,310

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

395 Outperform
28 Underperform
 

All-Star Players

23 Outperform
12 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ:ONVO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

gtechie (81.12)
Submitted May 20, 2015

5 years might even be too short of a timeframe to judge this company, but I want "in on the ground floor." Thumbs up.

pigsfeet007 (90.88)
Submitted April 10, 2014

I've spent several hours reading the short reports and the hype articles. This company, formerly known as Real Estate Restoration and Rental Inc., just doesn't smell right. I encourage you to dig into the SEC filings or watch one of the company's… More

NASDAQ:ONVO VS S&P 500 (SPY)

Fools bullish on NASDAQ:ONVO are also bullish on:

Fools bearish on NASDAQ:ONVO are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ONVO.

Recs

0
Member Avatar TheLibrarian (73.49) Submitted: 4/14/2016 1:29:05 AM : Outperform Start Price: $2.52 NASDAQ:ONVO Score: -131.24

Whereas 3D printing in itself offers great investment opportunity for the next 10 years, Organovo plans to use the technology to print lifelike human organs for drug testing purposes, and eventually use organs for transplantation. Naysayers often remark that the technology is too young and any investment at this point would be too early, but the technology is coming, and this opportunity won't be available at this price forever.

Recs

0
Member Avatar StockGambler (< 20) Submitted: 1/23/2016 3:47:34 PM : Outperform Start Price: $2.01 NASDAQ:ONVO Score: -140.60

Organovo Holdings does 3-D printing of live tissue. Currently liver tissue, with kidney tissue in the pipeline. Bioprinted living tissue can greatly reduce testing expenses for big pharma. Their are major advantages over using rats or mice, or removing tissue for testing. While other 3-D processes have fallen out of favor, this process holds great promise. See the director of R&D Tissue Applications discuss the process on their website
http://www.organovo.com/deb-nguyen-12-2013-podcast
This podcast is quite informative,

Recs

1
Member Avatar gtechie (81.12) Submitted: 5/20/2015 9:46:17 AM : Outperform Start Price: $4.58 NASDAQ:ONVO Score: -136.97

5 years might even be too short of a timeframe to judge this company, but I want "in on the ground floor." Thumbs up.

Leaderboard

Find the members with the highest scoring picks in ONVO.

Score Leader

MAKmeMONEY

MAKmeMONEY (97.99) Score: +333.02

The Score Leader is the player with the highest score across all their picks in ONVO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
bluebare 42.24 11/13/2012 Underperform 5Y $2.31 -78.09% +128.40% +206.49 0 Comment
tortoisetriguy 85.89 1/22/2013 Underperform 3M $4.90 -89.66% +112.26% +201.92 0 Comment
Retirefunds < 20 8/17/2012 Underperform 5Y $2.16 -76.57% +121.79% +198.36 0 Comment
macvel 67.53 5/6/2013 Underperform 5Y $4.30 -88.23% +94.97% +183.20 0 Comment
comsecga 53.40 5/10/2013 Underperform NS $4.45 -88.63% +93.17% +181.80 0 Comment
DarielFool 52.24 7/16/2013 Underperform 3M $6.68 -92.43% +87.87% +180.29 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. pigsfeet007 90.88 10/7/2013 Underperform 5Y $5.90 -91.42% +88.06% +179.48 3 Comments
Quaker08 27.47 8/15/2013 Underperform 5Y $5.74 -91.18% +88.07% +179.25 0 Comment
zman4money 40.92 5/16/2013 Underperform 5Y $4.20 -87.95% +89.92% +177.87 0 Comment
lorteungen 99.54 8/13/2013 Underperform 5Y $5.66 -91.06% +85.85% +176.91 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ONVO.